Develop policies for inclusion of new drugs into a hospital formulary, emergency drug list preparation, and automatic stop orders. Create assignment answer for 8pages (A4 sheet) Please create word file

Reading File

Finding Sources

Searching the Web

hospital formulary inclusion policy emergency drug list automatic stop orders pharmacy therapeutics committee guidelines

Reading File

Reading Web Page

https://www.epnetwork.org/wp-content/uploads/2019/10/Drugs-a…

Running Command

ls -la /tmp/workspace/ 2>/dev/null || mkdir -p /tmp/workspace && echo "created"

Just share the content

Here is the full assignment content (~8 A4 pages):

HOSPITAL DRUG POLICIES: FORMULARY INCLUSION, EMERGENCY DRUG LIST, AND AUTOMATIC STOP ORDERS

Assignment | Hospital Pharmacy Management | B.Pharm / Pharm.D / M.Pharm

INTRODUCTION

A hospital is a complex, multi-specialty healthcare institution where hundreds of drugs are prescribed, dispensed, and administered daily. Rational drug use, patient safety, and cost-effectiveness are primary concerns of any modern hospital pharmacy. To achieve these goals, hospitals rely on structured drug policies developed and maintained by the Pharmacy and Therapeutics (P&T) Committee - a standing advisory committee composed of physicians, pharmacists, nurses, and administrators.

Three of the most important drug policies in a hospital setting are:

Policy for Inclusion of New Drugs into the Hospital Formulary
Emergency Drug List Preparation
Automatic Stop Order Policy

These policies ensure that only evidence-based, safe, and cost-effective drugs are used; that life-saving drugs are immediately available in emergencies; and that prolonged, unnecessary drug use is prevented. This assignment discusses each policy in detail.

PART I: POLICY FOR INCLUSION OF NEW DRUGS INTO THE HOSPITAL FORMULARY

1.1 Definition of Hospital Formulary

A hospital formulary (also called the Essential Medicines List or Drug Formulary) is a continually updated, approved list of medications and related information that represents the clinical judgment of physicians, pharmacists, and other healthcare experts for the diagnosis, prophylaxis, or treatment of disease within that institution. It includes:

A list of approved medications and dosage forms
Medication-use policies
Ancillary drug information and clinical guidelines
Decision-support tools

As defined by the American Society of Health-System Pharmacists (ASHP), a formulary system is "the ongoing process through which a healthcare organization establishes policies regarding the use of drugs, therapies, and drug-related products and identifies those that are most medically appropriate and cost-effective to best serve the health interests of a given patient population."

The formulary system began in the 1940s in the military and gained widespread adoption in the 1950s-60s. Today it is the backbone of rational hospital drug use.

1.2 The Pharmacy and Therapeutics (P&T) Committee

The P&T Committee is the governing body responsible for formulary management. Its composition typically includes:

Member	Role
Chairperson (usually a senior physician)	Overall leadership
Hospital pharmacist / Chief pharmacist	Drug evaluation and implementation
Physicians from various specialties	Clinical input
Nursing representative	Administration perspective
Hospital administrator	Cost and resource perspective
Microbiologist / Infection control officer	Antimicrobial stewardship
Quality officer	Safety and compliance

Functions of the P&T Committee:

Advise medical staff and administration on all drug-related matters
Develop and update the hospital formulary
Establish policies on prescribing, dispensing, and administration
Monitor adverse drug reactions and medication errors
Develop standard treatment guidelines
Conduct educational programs for staff
Participate in emergency preparedness planning related to pharmaceuticals
Perform drug utilization reviews (DUR) and drug use evaluations (DUE)

1.3 Need for a Formulary Inclusion Policy

Without a clear policy, the hospital risks:

Stocking irrational, unproven, or redundant drugs
Pharmaceutical company influence on drug selection
Escalating drug costs without clinical benefit
Duplication of drug classes without therapeutic advantage
Patient safety risks from unfamiliar drugs

A structured inclusion policy ensures transparency, evidence-based decision-making, and equity in drug selection.

1.4 Criteria for Inclusion of New Drugs

A drug is eligible for formulary inclusion based on the following criteria:

a) Efficacy

The drug must have demonstrated clinical efficacy in well-designed clinical trials (Phase II, III, or IV)
Evidence from systematic reviews, meta-analyses, or randomized controlled trials (RCTs) is preferred
The drug should offer a therapeutic advantage over existing formulary drugs in the same class
Off-label uses must be supported by adequate evidence from peer-reviewed literature

b) Safety

The drug's adverse effect profile must be acceptable relative to its benefit
Known contraindications, drug-drug interactions, and teratogenicity must be documented
Sound-alike/look-alike (SALA) potential must be assessed
Post-marketing surveillance data and pharmacovigilance reports must be reviewed
Narrow therapeutic index drugs require additional scrutiny

c) Quality / Pharmaceutical Standards

The drug must be approved by the national regulatory authority (e.g., CDSCO in India, FDA in USA, EMA in Europe)
It must comply with pharmacopoeial standards (IP, BP, USP)
Manufacturing practices (GMP) of the supplier must be verified

d) Cost-Effectiveness

Cost compared to existing therapeutically equivalent drugs must be analyzed
Pharmacoeconomic data (cost-benefit, cost-effectiveness, cost-utility analysis) should be provided
Total cost of therapy (not just drug cost) must be considered, including administration, monitoring, and adverse effect management

e) Need and Relevance

The drug must address a disease or condition prevalent in the hospital's patient population
There should be no adequate therapeutically equivalent drug already on the formulary, OR the new drug should offer a clear clinical advantage
Alignment with national and institutional standard treatment guidelines (STGs)

f) Availability and Supply

Reliable, uninterrupted supply from a reputable manufacturer or supplier must be ensured
The drug should be available in appropriate dosage forms and strengths suitable for the hospital's patient population (pediatric, geriatric, renal/hepatic impaired)

1.5 Procedure for Formulary Addition

Step 1: Submission of Request

Any physician, pharmacist, or department head may submit a formal Drug Addition Request Form
The form includes: generic name, brand name, manufacturer, pharmacological class, proposed indication, dosage, route of administration, cost data, and supporting literature
The applicant must declare any conflict of interest (financial support from the drug manufacturer)
Individual doctors must obtain endorsement from their Head of Department

Step 2: Preliminary Review by Pharmacy Department

The Chief Pharmacist/Pharmacy Department reviews completeness of the submission
A preliminary pharmacological summary is prepared
Duplicate therapeutic class check is performed against the existing formulary

Step 3: Evidence Evaluation by P&T Committee

The committee evaluates:
- Published clinical evidence (efficacy and safety data)
- Comparative effectiveness vs. existing drugs
- Regulatory approval status
- Cost-effectiveness analysis
- Pharmacovigilance data
A drug monograph is prepared using standardized templates (ASHP format recommended)

Step 4: Committee Decision

The P&T Committee votes on the addition
Possible outcomes:
- Approved - added to formulary unrestricted
- Approved with restrictions - limited to specific specialties, diagnoses, or patient criteria
- Deferred - pending additional information
- Rejected - not added to formulary
Decisions are recorded in the minutes and communicated to all departments

Step 5: Implementation

The formulary is updated and circulated
Pharmacy procurement is notified
Medical and nursing staff are educated on the new addition
Usage criteria and monitoring parameters are documented

Step 6: Periodic Review

All formulary drugs are reviewed at least annually (or more frequently if new safety signals emerge)
Drugs may be deleted from the formulary if:
- Safer/more effective alternatives become available
- New serious adverse effects are identified
- Usage is minimal with no clinical justification
- The drug is withdrawn from the market

1.6 Non-Formulary Drug Requests

In exceptional clinical situations, a non-formulary drug may be prescribed:

The prescribing physician must complete a Non-Formulary Drug Request Form
Authorization from a Senior Consultant and the Chief Pharmacist is required
These requests are reviewed by the P&T Committee to identify whether formulary addition is warranted

PART II: EMERGENCY DRUG LIST PREPARATION

2.1 Definition and Purpose

An Emergency Drug List (EDL) is a pre-determined, standardized list of drugs that must be immediately available in a hospital or clinical unit to manage life-threatening emergencies. These drugs must be accessible at all times - 24 hours a day, 7 days a week - without delay.

The primary purpose of the EDL is to:

Prevent death and serious harm from delay in treatment
Ensure first-responders have the necessary drugs within immediate reach
Standardize emergency drug management across all hospital units
Reduce errors during high-stress emergency situations

2.2 Principles of Emergency Drug List Preparation

The EDL is prepared based on:

Life-threatening conditions managed in the hospital (cardiac arrest, anaphylaxis, status epilepticus, respiratory failure, hypoglycemia, acute poisoning, etc.)
Frequency of emergency events in that institution's patient population
Rapid onset of action - drugs selected must act quickly
Evidence-based selection - only drugs with proven efficacy in emergency settings are included
Standard treatment guidelines (national and international) for emergency care
Simplicity - the list must be manageable; too many drugs cause confusion during emergencies
Stability - drugs on the emergency list must have acceptable shelf-life under storage conditions

2.3 Classification of Emergency Drugs

Emergency drugs may be classified by the type of emergency they address:

A. Cardiac Emergencies

Drug	Indication
Adrenaline (Epinephrine) 1:1000	Cardiac arrest, anaphylaxis
Atropine	Bradycardia, organophosphate poisoning
Amiodarone	Ventricular fibrillation, tachyarrhythmias
Adenosine	SVT (Supraventricular tachycardia)
Lignocaine (Lidocaine)	Ventricular arrhythmias
Sodium bicarbonate	Metabolic acidosis, cardiac arrest
Calcium gluconate	Hyperkalemia, calcium channel blocker overdose

B. Respiratory Emergencies

Drug	Indication
Salbutamol (nebulization)	Acute bronchospasm, asthma
Hydrocortisone	Acute severe asthma, anaphylaxis
Aminophylline	Severe bronchospasm
Oxygen	All respiratory emergencies
Naloxone	Opioid-induced respiratory depression

C. Neurological Emergencies

Drug	Indication
Diazepam IV/rectal	Status epilepticus
Lorazepam IV	Status epilepticus
Phenytoin IV	Status epilepticus (loading)
Phenobarbitone IV	Refractory seizures
Mannitol	Raised intracranial pressure
Dextrose 25%/50%	Hypoglycemic coma

D. Metabolic/Endocrine Emergencies

Drug	Indication
Dextrose 25%	Hypoglycemia
Regular (soluble) insulin	Diabetic ketoacidosis, hyperkalemia
Thiamine	Wernicke's encephalopathy
Hydrocortisone	Adrenal crisis

E. Anaphylaxis

Drug	Indication
Epinephrine 1:1000 IM	First line in anaphylaxis
Chlorpheniramine IV	Antihistamine adjunct
Hydrocortisone IV	Adjunct therapy
IV Normal saline	Volume replacement

F. Antidotes and Toxicology

Drug	Indication
Naloxone	Opioid overdose
Flumazenil	Benzodiazepine overdose
N-acetylcysteine	Paracetamol (acetaminophen) overdose
Atropine + Pralidoxime	Organophosphate poisoning
Activated charcoal	Oral poisoning (within 1 hour)
Vitamin K	Warfarin overdose

G. Obstetric Emergencies

Drug	Indication
Oxytocin	Postpartum hemorrhage
Ergometrine	Postpartum hemorrhage
Magnesium sulfate	Eclampsia, preeclampsia
Nifedipine / Labetalol	Hypertensive emergency in pregnancy

2.4 Location and Storage of Emergency Drugs

Emergency drug trolleys / crash carts are placed in all critical areas: ICU, CCU, NICU, OT, Emergency Department, and each ward
Each crash cart must have a standardized layout with labeled compartments
Drugs are stored in sealed trays or lock boxes - a broken seal immediately indicates unauthorized use
Temperature-sensitive drugs (e.g., adrenaline, insulin) must be stored at appropriate temperatures
The crash cart must be checked daily by the duty nurse/pharmacist and after every use
A logbook is maintained for each crash cart recording inspection date, seal number, and responsible staff
Expiry dates are checked and documented; drugs nearing expiry are replaced promptly

2.5 Procedure for Use of Emergency Drugs

In a medical emergency, the senior-most clinician present directs drug use
Drugs are drawn up and administered by authorized nursing/medical staff
All drugs used are documented in the emergency record/resuscitation record
After an emergency event, the crash cart is restocked by the pharmacy within a defined time (usually 1-2 hours)
A root cause analysis is performed after every cardiac arrest or major emergency event to identify system gaps

2.6 Review and Updating of the Emergency Drug List

The EDL is reviewed annually by the P&T Committee
Changes in clinical guidelines (e.g., updated ACLS/BLS protocols) trigger immediate review
New evidence on drug efficacy/safety in emergencies prompts reassessment
Drugs with persistent supply issues are replaced with readily available alternatives
Feedback from clinical staff who have used emergency drugs is incorporated

2.7 Staff Training

All clinical staff must be trained in the location and correct use of emergency drugs
Regular mock codes (simulated emergency drills) are conducted
Training is documented and records maintained by the Education department
BLS and ACLS certification is mandatory for ICU, ED, and OT staff

PART III: AUTOMATIC STOP ORDER POLICY

3.1 Definition

An Automatic Stop Order (ASO) is a hospital policy that requires certain drug orders to be automatically discontinued - without explicit prescriber action - after a predetermined time period, unless the prescriber actively renews the order. It is a form of built-in safeguard against unintentional prolonged drug therapy.

As stated in Katzung's Basic and Clinical Pharmacology (16th ed.): "If the duration of therapy or the number of doses is not specified (which is often the case), the medication is continued until the prescriber discontinues the order or until it is terminated as a matter of policy routine, e.g., a stop-order policy."

3.2 Rationale and Need for Automatic Stop Orders

Without automatic stop orders:

Patients may receive antibiotics for weeks because the physician forgot to discontinue the order
Patients may inadvertently receive controlled substances beyond the clinically necessary period
Post-operative drugs may be continued unnecessarily, increasing costs and adverse effects
Anticoagulants and narcotic analgesics may be continued beyond the safe period, risking bleeding or dependence
Prolonged use of broad-spectrum antibiotics contributes to antimicrobial resistance

The World Health Organization's Drug and Therapeutics Committee practical guide emphasizes: "Automatic stop orders are useful for hospital patients and will enforce restrictions on the period of time for which drugs are used... patients may be left on antibiotics for a long period of time because physicians have neglected to discontinue the medicine."

3.3 Categories of Drugs Subject to Automatic Stop Orders

Different drug categories have different ASO time limits, which are established by the P&T Committee based on clinical evidence and standard treatment guidelines:

Drug Category	Typical ASO Time Limit	Rationale
Antibiotics (general)	48-72 hours	Review culture reports; de-escalate
Prophylactic antibiotics (surgical)	24-48 hours post-op	Extended use increases resistance risk
Narcotic / Opioid analgesics	48-72 hours	Prevent dependence; pain reassessment
Anticoagulants (heparin, warfarin)	72 hours or per protocol	Reassess bleeding risk; adjust doses
Sedatives / Hypnotics	48-72 hours	Prevent tolerance and dependence
Controlled substances (Schedule I-II)	48-72 hours	Legal and clinical safety
Corticosteroids (systemic)	7 days	Reassess need; taper plan
Antifungals	72 hours	Review necessity and culture results
IV fluids (specific orders)	24 hours	Reassess fluid status daily
Total Parenteral Nutrition (TPN)	24-48 hours	Daily reassessment of nutritional needs

Note: Exact time limits are determined by each hospital's P&T Committee and may vary.

3.4 Drugs Exempt from Automatic Stop Orders

The following categories are generally exempt from ASO (but are still subject to periodic review):

Chronic maintenance drugs (antihypertensives, antidiabetics, cardiac drugs) continued from home
Thyroid replacement therapy
Drugs for chronic psychiatric conditions (antipsychotics, antidepressants) unless newly initiated
Drugs for chronic pain conditions under specialist supervision
Insulin (routine maintenance doses for diabetic patients)

3.5 Automatic Stop Order Policy: Standard Procedure

Step 1: Order Entry

When a physician writes a drug order, the drug category is identified by the pharmacist/pharmacy system
For drugs subject to ASO, the order automatically carries an expiration timestamp
In electronic health record (EHR) systems, the ASO is programmed into the order entry system
In paper-based systems, the pharmacist stamps the order with the stop date/time

Step 2: Notification Before Expiry

The treating physician is notified 24-48 hours before the stop order takes effect
Notification methods: EHR alert, pharmacist communication, nursing notification
The physician reviews the clinical status and decides to:
- Renew the order with a new stop date (active renewal)
- Modify the order (change drug, dose, route, or duration)
- Discontinue the order as scheduled

Step 3: Automatic Discontinuation

If no renewal is received, the order is automatically discontinued at the specified time
The pharmacy does not dispense further doses after the stop time
The nursing staff is informed not to administer additional doses
The discontinuation is documented in the patient's medical record

Step 4: Documentation

All ASO events are logged in the pharmacy system and patient chart
The reason for stop, date, time, and name of drug are recorded
If the patient's clinical status was adversely affected due to the stop, it is reported as a near-miss or adverse event

Step 5: Audit and Review

The P&T Committee reviews ASO compliance monthly or quarterly
Cases where ASO was inappropriately bypassed are identified and corrective action is taken
Clinical outcomes linked to ASO enforcement are tracked

3.6 Special Provisions

Emergency override: In critical clinical situations, any authorized physician may override an ASO with proper documentation
Surgical patients: Post-operative prophylactic antibiotics have the most rigidly enforced ASO timelines
ICU patients: ASO in ICU is applied with clinical judgment - the attending intensivist reviews all expiring orders daily
On transfer between units: All drug orders are reviewed when a patient transfers from one unit (e.g., ICU to ward); ASO timers may reset
At discharge: All inpatient orders automatically cease; a new prescription is required for outpatient continuation

3.7 Benefits of Automatic Stop Order Policy

Reduces medication errors from unintentional prolonged therapy
Prevents antimicrobial resistance by limiting unnecessary antibiotic use
Reduces adverse drug reactions from prolonged exposure
Decreases drug costs by eliminating unnecessary drug utilization
Ensures periodic reassessment of the patient's clinical condition and drug needs
Supports antimicrobial stewardship programs (ASP)
Improves prescriber accountability and awareness of drug orders
Legal protection - documented stop orders reduce medico-legal risk

3.8 Challenges in Implementation

Challenge	Solution
Prescriber resistance / workflow disruption	Education; involve physicians in policy design
Risk of stopping a clinically necessary drug	24-48 hr advance notification; easy renewal process
Complex paper-based systems	EHR integration; pharmacist oversight
Inconsistent application across departments	Standardized policy; regular audits
Emergency situations requiring immediate override	Clear override protocol with documentation

PART IV: INTERRELATIONSHIP OF THE THREE POLICIES

These three policies are not isolated but are deeply interconnected within the hospital drug management system:

Formulary inclusion policy determines which drugs are available in the hospital
Emergency drug list ensures that a subset of critical drugs are always immediately accessible
Automatic stop orders regulate how long drugs are used once prescribed

Together, they form the triad of rational drug use in hospitals:

Formulary Policy → Selects safe, effective, cost-efficient drugs
       ↓
Emergency Drug List → Ensures life-saving drugs are always available
       ↓
Automatic Stop Orders → Prevents unnecessary prolonged use
       ↓
Outcome: Safe, effective, rational, and cost-conscious pharmacotherapy

All three are governed and maintained by the P&T Committee, which acts as the central authority for hospital drug management. They are aligned with:

WHO Essential Medicines Concept
ASHP Formulary System Guidelines
National Pharmaceutical Pricing and Drug Policy (NPPA, India)
Joint Commission International (JCI) Accreditation Standards
NABH (National Accreditation Board for Hospitals) Standards

CONCLUSION

Hospital drug policies are the foundation of safe and rational drug use. The formulary inclusion policy ensures only evidence-based, cost-effective, and safe drugs are stocked and used in the hospital, guided by a transparent and structured evaluation process led by the P&T Committee. The emergency drug list guarantees that life-saving drugs are available within seconds when a patient's life is at risk, with standardized crash carts, regular inspection, and staff training. The automatic stop order policy acts as a systematic safeguard against unintentional prolonged prescribing, reducing adverse effects, resistance, costs, and prescribing errors.

Together, these three policies reflect the highest standards of hospital pharmacy practice and patient safety. Their effective implementation requires strong institutional commitment, interdisciplinary collaboration, regular audit, and continuous staff education. Pharmacists play a central role in developing, implementing, monitoring, and improving all three policies.

REFERENCES

Katzung BG, Vanderah TW. Basic and Clinical Pharmacology, 16th ed. McGraw-Hill; 2021. Chapter 66: Prescribing Principles.
World Health Organization. Drug and Therapeutics Committees: A Practical Guide. WHO/EDM/PAR/2004.1. Geneva: WHO; 2004.
American Society of Health-System Pharmacists (ASHP). Draft ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System; 2019.
Ministry of Health, Saudi Arabia. National Formulary Drug List: Drug Control Policies and Guidelines; 2020.
University of Toledo Medical Center. Pharmacy and Therapeutics Committee Policy 3364-87-19; 2023.
Tietz Textbook of Laboratory Medicine, 7th ed. Elsevier; 2023. Section on Stewardship Committees.
Joint Commission International. Accreditation Standards for Hospitals, 7th ed; 2021.
National Accreditation Board for Hospitals and Healthcare Providers (NABH). Standards for Hospitals, 5th ed. New Delhi: Quality Council of India; 2020.

Word count: ~3,800 words | Approximate pages: 8 A4 pages (Times New Roman 12pt, 1.5 line spacing)

This covers all three policies with full depth suitable for an 8-page assignment. Let me know if you want any section expanded, a table of contents added, or the Word (.docx) file generated after all.

Generate a Word (.docx) file of this assignment content with professional formatting

Running Command

mkdir -p /tmp/workspace/hospital-drug-policy && cat > /tmp/workspace/hospital-drug-policy/create_doc.py << 'PYEOF' from docx import Document from docx.shared import Pt, Inches, RGBColor, Cm from docx.enum.text import WD_ALIGN_PARAGRAPH from docx.enum.table import WD_TABLE_ALIGNMENT, WD_ALIGN_VERTICAL from docx.oxml.ns import qn from docx.oxml import OxmlElement import copy doc = Document() # ── Page setup: A4 ────────────────────────────────────────────────────────── section = doc.sections[0] section.page_height = Cm(29.7) section.page_width = Cm(21.0) section.left_margin = Cm(2.54) section.right_margin = Cm(2.54) section.top_margin = Cm(2.54) section.bottom_margin = Cm(2.54) # ── Colour palette ─────────────────────────────────────────────────────────── DARK_BLUE = RGBColor(0x1A, 0x3A, 0x6B) # headings MID_BLUE = RGBColor(0x2E, 0x6D, 0xB4) # sub-headings ACCENT = RGBColor(0x0D, 0x47, 0xA1) # table header bg WHITE = RGBColor(0xFF, 0xFF, 0xFF) LIGHT_GREY = RGBColor(0xF2, 0xF2, 0xF2) # table alt-rows TEXT_BLACK = RGBColor(0x1A, 0x1A, 0x1A) # ── Helper: set paragraph shading ─────────────────────────────────────────── def shade_paragraph(para, hex_color): pPr = para._p.get_or_add_pPr() shd = OxmlElement('w:shd') shd.set(qn('w:val'), 'clear') shd.set(qn('w:color'), 'auto') shd.set(qn('w:fill'), hex_color) pPr.append(shd) # ── Helper: set cell background ────────────────────────────────────────────── def set_cell_bg(cell, hex_color): tc = cell._tc tcPr = tc.get_or_add_tcPr() shd = OxmlElement('w:shd') shd.set(qn('w:val'), 'clear') shd.set(qn('w:color'), 'auto') shd.set(qn('w:fill'), hex_color) tcPr.append(shd) # ── Helper: set cell borders ───────────────────────────────────────────────── def set_table_borders(table): tbl = table._tbl tblPr = tbl.tblPr if tbl.tblPr is not None else OxmlElement('w:tblPr') tblBorders = OxmlElement('w:tblBorders') for border_name in ('top','left','bottom','right','insideH','insideV'): b = OxmlElement(f'w:{border_name}') b.set(qn('w:val'), 'single') b.set(qn('w:sz'), '4') b.set(qn('w:space'), '0') b.set(qn('w:color'), '2E6DB4') tblBorders.append(b) tblPr.append(tblBorders) # ── Helper: add horizontal rule ────────────────────────────────────────────── def add_hr(doc, color_hex='2E6DB4', width_pt=1): p = doc.add_paragraph() pPr = p._p.get_or_add_pPr() pb = OxmlElement('w:pBdr') bot = OxmlElement('w:bottom') bot.set(qn('w:val'), 'single') bot.set(qn('w:sz'), str(int(width_pt * 8))) bot.set(qn('w:space'), '1') bot.set(qn('w:color'), color_hex) pb.append(bot) pPr.append(pb) p.paragraph_format.space_before = Pt(0) p.paragraph_format.space_after = Pt(4) return p # ── Helper: styled heading ─────────────────────────────────────────────────── def add_main_heading(doc, text): p = doc.add_paragraph() p.paragraph_format.space_before = Pt(14) p.paragraph_format.space_after = Pt(4) run = p.add_run(text) run.bold = True run.font.size = Pt(14) run.font.color.rgb = DARK_BLUE run.font.name = 'Calibri' # underline accent bar via bottom border pPr = p._p.get_or_add_pPr() pb = OxmlElement('w:pBdr') bot = OxmlElement('w:bottom') bot.set(qn('w:val'), 'single') bot.set(qn('w:sz'), '8') bot.set(qn('w:space'), '1') bot.set(qn('w:color'), '1A3A6B') pb.append(bot) pPr.append(pb) return p def add_sub_heading(doc, text): p = doc.add_paragraph() p.paragraph_format.space_before = Pt(10) p.paragraph_format.space_after = Pt(2) run = p.add_run(text) run.bold = True run.font.size = Pt(12) run.font.color.rgb = MID_BLUE run.font.name = 'Calibri' return p def add_sub_sub_heading(doc, text): p = doc.add_paragraph() p.paragraph_format.space_before = Pt(8) p.paragraph_format.space_after = Pt(2) run = p.add_run(text) run.bold = True run.italic = True run.font.size = Pt(11) run.font.color.rgb = DARK_BLUE run.font.name = 'Calibri' return p def add_body(doc, text, italic=False, bold=False): p = doc.add_paragraph() p.paragraph_format.space_before = Pt(2) p.paragraph_format.space_after = Pt(4) p.paragraph_format.first_line_indent = Pt(0) run = p.add_run(text) run.font.size = Pt(11) run.font.name = 'Calibri' run.font.color.rgb = TEXT_BLACK run.italic = italic run.bold = bold return p def add_bullet(doc, text, level=0): p = doc.add_paragraph(style='List Bullet') p.paragraph_format.space_before = Pt(1) p.paragraph_format.space_after = Pt(1) p.paragraph_format.left_indent = Inches(0.25 + 0.2*level) run = p.add_run(text) run.font.size = Pt(11) run.font.name = 'Calibri' run.font.color.rgb = TEXT_BLACK return p # ── Helper: build a styled table ───────────────────────────────────────────── def make_table(doc, headers, rows, col_widths=None): table = doc.add_table(rows=1 + len(rows), cols=len(headers)) table.alignment = WD_TABLE_ALIGNMENT.CENTER set_table_borders(table) # Header row hdr = table.rows[0] for i, h in enumerate(headers): cell = hdr.cells[i] set_cell_bg(cell, '1A3A6B') cell.vertical_alignment = WD_ALIGN_VERTICAL.CENTER p = cell.paragraphs[0] p.alignment = WD_ALIGN_PARAGRAPH.CENTER p.paragraph_format.space_before = Pt(3) p.paragraph_format.space_after = Pt(3) run = p.add_run(h) run.bold = True run.font.size = Pt(10) run.font.color.rgb = WHITE run.font.name = 'Calibri' # Data rows for r_idx, row_data in enumerate(rows): row = table.rows[r_idx + 1] bg = 'F2F7FF' if r_idx % 2 == 0 else 'FFFFFF' for c_idx, cell_text in enumerate(row_data): cell = row.cells[c_idx] set_cell_bg(cell, bg) cell.vertical_alignment = WD_ALIGN_VERTICAL.CENTER p = cell.paragraphs[0] p.alignment = WD_ALIGN_PARAGRAPH.LEFT p.paragraph_format.space_before = Pt(2) p.paragraph_format.space_after = Pt(2) run = p.add_run(cell_text) run.font.size = Pt(10) run.font.name = 'Calibri' run.font.color.rgb = TEXT_BLACK # Column widths if col_widths: for row in table.rows: for i, w in enumerate(col_widths): row.cells[i].width = Inches(w) doc.add_paragraph().paragraph_format.space_after = Pt(4) return table # ════════════════════════════════════════════════════════════════════════════ # COVER / TITLE BLOCK # ════════════════════════════════════════════════════════════════════════════ # Title banner paragraph with shading title_p = doc.add_paragraph() title_p.alignment = WD_ALIGN_PARAGRAPH.CENTER title_p.paragraph_format.space_before = Pt(0) title_p.paragraph_format.space_after = Pt(0) shade_paragraph(title_p, '1A3A6B') run = title_p.add_run('HOSPITAL DRUG POLICIES') run.bold = True; run.font.size = Pt(20); run.font.color.rgb = WHITE; run.font.name = 'Calibri' sub_p = doc.add_paragraph() sub_p.alignment = WD_ALIGN_PARAGRAPH.CENTER sub_p.paragraph_format.space_before = Pt(0) sub_p.paragraph_format.space_after = Pt(0) shade_paragraph(sub_p, '2E6DB4') run = sub_p.add_run('Formulary Inclusion | Emergency Drug List | Automatic Stop Orders') run.bold = True; run.font.size = Pt(13); run.font.color.rgb = WHITE; run.font.name = 'Calibri' # Meta info table (no borders, just structure) meta = doc.add_table(rows=3, cols=2) meta.alignment = WD_TABLE_ALIGNMENT.CENTER for r, (lbl, val) in enumerate([ ('Subject:', 'Hospital Pharmacy Management'), ('Course:', 'B.Pharm / Pharm.D / M.Pharm'), ('Date:', 'July 2026'), ]): lc = meta.rows[r].cells[0] vc = meta.rows[r].cells[1] lc.width = Inches(1.5); vc.width = Inches(4.5) lp = lc.paragraphs[0] lp.paragraph_format.space_before = Pt(2); lp.paragraph_format.space_after = Pt(2) lr = lp.add_run(lbl); lr.bold=True; lr.font.size=Pt(11); lr.font.name='Calibri'; lr.font.color.rgb=DARK_BLUE vp = vc.paragraphs[0] vp.paragraph_format.space_before = Pt(2); vp.paragraph_format.space_after = Pt(2) vr = vp.add_run(val); vr.font.size=Pt(11); vr.font.name='Calibri'; vr.font.color.rgb=TEXT_BLACK add_hr(doc, '1A3A6B', 2) # ════════════════════════════════════════════════════════════════════════════ # INTRODUCTION # ════════════════════════════════════════════════════════════════════════════ add_main_heading(doc, 'INTRODUCTION') add_body(doc, 'A hospital is a complex, multi-specialty healthcare institution where hundreds of drugs are prescribed, dispensed, and administered daily. Rational drug use, patient safety, and cost-effectiveness are primary concerns of any modern hospital pharmacy. To achieve these goals, hospitals rely on structured drug policies developed and maintained by the Pharmacy and Therapeutics (P&T) Committee - a standing advisory committee composed of physicians, pharmacists, nurses, and administrators.') add_body(doc, 'Three of the most important drug policies in a hospital setting are:') add_bullet(doc, 'Policy for Inclusion of New Drugs into the Hospital Formulary') add_bullet(doc, 'Emergency Drug List Preparation') add_bullet(doc, 'Automatic Stop Order Policy') add_body(doc, 'These policies ensure that only evidence-based, safe, and cost-effective drugs are used; that life-saving drugs are immediately available in emergencies; and that prolonged, unnecessary drug use is prevented.') # ════════════════════════════════════════════════════════════════════════════ # PART I # ════════════════════════════════════════════════════════════════════════════ add_main_heading(doc, 'PART I: POLICY FOR INCLUSION OF NEW DRUGS INTO THE HOSPITAL FORMULARY') add_sub_heading(doc, '1.1 Definition of Hospital Formulary') add_body(doc, 'A hospital formulary (also called the Essential Medicines List or Drug Formulary) is a continually updated, approved list of medications and related information representing the clinical judgment of physicians, pharmacists, and other healthcare experts for the diagnosis, prophylaxis, or treatment of disease within that institution. It includes:') for item in ['A list of approved medications and dosage forms','Medication-use policies','Ancillary drug information and clinical guidelines','Decision-support tools']: add_bullet(doc, item) add_body(doc, 'As defined by the American Society of Health-System Pharmacists (ASHP): "A formulary system is the ongoing process through which a healthcare organization establishes policies regarding the use of drugs, therapies, and drug-related products and identifies those that are most medically appropriate and cost-effective to best serve the health interests of a given patient population."', italic=True) add_sub_heading(doc, '1.2 The Pharmacy and Therapeutics (P&T) Committee') add_body(doc, 'The P&T Committee is the governing body responsible for formulary management. Its composition and functions are shown below.') make_table(doc, ['Member', 'Role'], [ ['Chairperson (Senior Physician)', 'Overall leadership and final decisions'], ['Chief Pharmacist', 'Drug evaluation and formulary implementation'], ['Specialist Physicians', 'Clinical input from respective specialties'], ['Nursing Representative', 'Administration and patient care perspective'], ['Hospital Administrator', 'Cost, logistics, and resource allocation'], ['Microbiologist / Infection Control Officer', 'Antimicrobial stewardship'], ['Quality Officer', 'Safety, compliance, and accreditation'], ], col_widths=[2.8, 3.6] ) add_body(doc, 'Key functions of the P&T Committee include:') for f in [ 'Advise medical staff and administration on all drug-related matters', 'Develop, update, and maintain the hospital formulary', 'Establish policies on prescribing, dispensing, and administration', 'Monitor adverse drug reactions (ADRs) and medication errors', 'Develop and update standard treatment guidelines (STGs)', 'Conduct drug utilization reviews (DUR) and drug use evaluations (DUE)', 'Participate in emergency preparedness planning related to pharmaceuticals', 'Conduct educational programs for medical, nursing, and pharmacy staff', ]: add_bullet(doc, f) add_sub_heading(doc, '1.3 Criteria for Inclusion of New Drugs') add_sub_sub_heading(doc, 'a) Efficacy') for b in ['Demonstrated clinical efficacy in well-designed Phase II, III, or IV clinical trials','Evidence from systematic reviews, meta-analyses, or randomized controlled trials (RCTs) preferred','Must offer a therapeutic advantage over existing formulary drugs in the same class','Off-label uses supported by adequate peer-reviewed literature']: add_bullet(doc, b) add_sub_sub_heading(doc, 'b) Safety') for b in ['Acceptable adverse effect profile relative to benefit','Known contraindications, drug-drug interactions, and teratogenicity fully documented','Sound-alike/look-alike (SALA) potential assessed','Post-marketing surveillance and pharmacovigilance reports reviewed','Narrow therapeutic index drugs require additional scrutiny']: add_bullet(doc, b) add_sub_sub_heading(doc, 'c) Quality / Pharmaceutical Standards') for b in ['Approved by the national regulatory authority (CDSCO/India, USFDA, EMA)','Complies with pharmacopoeial standards (IP, BP, USP)','Manufacturer GMP compliance verified']: add_bullet(doc, b) add_sub_sub_heading(doc, 'd) Cost-Effectiveness') for b in ['Pharmacoeconomic data (cost-benefit, cost-effectiveness, cost-utility analysis) provided','Total cost of therapy considered: drug cost + administration + monitoring + adverse effect management','Cost compared to existing therapeutically equivalent formulary drugs']: add_bullet(doc, b) add_sub_sub_heading(doc, 'e) Need and Relevance') for b in ['Must address a disease or condition prevalent in the hospital patient population','No adequate therapeutically equivalent drug already on formulary, OR new drug offers clear clinical advantage','Aligned with national and institutional standard treatment guidelines']: add_bullet(doc, b) add_sub_heading(doc, '1.4 Procedure for Formulary Drug Addition') make_table(doc, ['Step', 'Action', 'Responsible Party'], [ ['Step 1', 'Physician/Pharmacist submits Drug Addition Request Form with supporting literature and conflict-of-interest declaration', 'Requesting Physician / HOD'], ['Step 2', 'Pharmacy Department reviews completeness; prepares pharmacological summary; performs duplicate class check', 'Chief Pharmacist'], ['Step 3', 'P&T Committee evaluates evidence: efficacy, safety, cost, regulatory status, pharmacovigilance data', 'P&T Committee'], ['Step 4', 'Committee votes: Approved / Approved with restrictions / Deferred / Rejected', 'P&T Committee (Chairperson)'], ['Step 5', 'Formulary updated; procurement notified; staff educated; usage criteria documented', 'Pharmacy + Administration'], ['Step 6', 'Annual review of all formulary drugs; deletions if safety signals or better alternatives emerge', 'P&T Committee'], ], col_widths=[0.8, 3.8, 1.8] ) add_sub_heading(doc, '1.5 Non-Formulary Drug Requests') add_body(doc, 'In exceptional clinical situations, a non-formulary drug may be prescribed subject to:') for b in ['Completion of a Non-Formulary Drug Request Form by the prescribing physician','Authorization from a Senior Consultant and the Chief Pharmacist','P&T Committee review to assess whether formal formulary addition is warranted']: add_bullet(doc, b) # ════════════════════════════════════════════════════════════════════════════ # PART II # ════════════════════════════════════════════════════════════════════════════ add_main_heading(doc, 'PART II: EMERGENCY DRUG LIST PREPARATION') add_sub_heading(doc, '2.1 Definition and Purpose') add_body(doc, 'An Emergency Drug List (EDL) is a pre-determined, standardized list of drugs that must be immediately available in a hospital to manage life-threatening emergencies 24 hours a day, 7 days a week. The primary purposes are:') for b in ['Prevent death and serious harm from delay in treatment','Ensure first-responders have necessary drugs immediately accessible','Standardize emergency drug management across all hospital units','Reduce errors during high-stress emergency situations']: add_bullet(doc, b) add_sub_heading(doc, '2.2 Principles of Emergency Drug List Preparation') add_body(doc, 'The EDL is prepared based on:') for b in [ 'Life-threatening conditions managed in the hospital (cardiac arrest, anaphylaxis, status epilepticus, respiratory failure, hypoglycemia, acute poisoning)', 'Rapid onset of action - drugs must act quickly', 'Evidence-based selection - only drugs with proven efficacy in emergency settings', 'Simplicity - manageable list; too many drugs cause confusion during emergencies', 'Stability - drugs must have acceptable shelf-life under standard storage conditions', 'Alignment with standard emergency care guidelines (ACLS, BLS, national protocols)', ]: add_bullet(doc, b) add_sub_heading(doc, '2.3 Emergency Drug Categories and Examples') add_sub_sub_heading(doc, 'A. Cardiac Emergencies') make_table(doc, ['Drug', 'Indication'], [ ['Adrenaline (Epinephrine) 1:1000', 'Cardiac arrest, anaphylaxis'], ['Atropine', 'Bradycardia, organophosphate poisoning'], ['Amiodarone', 'Ventricular fibrillation, tachyarrhythmias'], ['Adenosine', 'Supraventricular tachycardia (SVT)'], ['Lignocaine (Lidocaine)', 'Ventricular arrhythmias'], ['Sodium Bicarbonate', 'Metabolic acidosis, cardiac arrest'], ['Calcium Gluconate', 'Hyperkalemia, calcium channel blocker overdose'], ], col_widths=[2.8, 3.6] ) add_sub_sub_heading(doc, 'B. Respiratory Emergencies') make_table(doc, ['Drug', 'Indication'], [ ['Salbutamol (nebulization)', 'Acute bronchospasm, asthma'], ['Hydrocortisone IV', 'Acute severe asthma, anaphylaxis'], ['Aminophylline', 'Severe bronchospasm'], ['Naloxone', 'Opioid-induced respiratory depression'], ], col_widths=[2.8, 3.6] ) add_sub_sub_heading(doc, 'C. Neurological Emergencies') make_table(doc, ['Drug', 'Indication'], [ ['Diazepam IV / Rectal', 'Status epilepticus (first line)'], ['Lorazepam IV', 'Status epilepticus'], ['Phenytoin IV', 'Status epilepticus (loading dose)'], ['Phenobarbitone IV', 'Refractory seizures'], ['Mannitol 20%', 'Raised intracranial pressure'], ['Dextrose 25% / 50%', 'Hypoglycemic coma'], ], col_widths=[2.8, 3.6] ) add_sub_sub_heading(doc, 'D. Anaphylaxis') make_table(doc, ['Drug', 'Indication'], [ ['Epinephrine 1:1000 IM', 'First line in anaphylaxis'], ['Chlorpheniramine IV', 'Antihistamine adjunct'], ['Hydrocortisone IV', 'Adjunct therapy'], ['IV Normal Saline 0.9%', 'Volume replacement'], ], col_widths=[2.8, 3.6] ) add_sub_sub_heading(doc, 'E. Antidotes and Toxicology') make_table(doc, ['Drug', 'Indication'], [ ['Naloxone', 'Opioid overdose'], ['Flumazenil', 'Benzodiazepine overdose'], ['N-acetylcysteine', 'Paracetamol (acetaminophen) overdose'], ['Atropine + Pralidoxime', 'Organophosphate poisoning'], ['Activated Charcoal', 'Oral poisoning (within 1 hour of ingestion)'], ['Vitamin K (Phytomenadione)', 'Warfarin / anticoagulant overdose'], ], col_widths=[2.8, 3.6] ) add_sub_sub_heading(doc, 'F. Obstetric Emergencies') make_table(doc, ['Drug', 'Indication'], [ ['Oxytocin', 'Postpartum hemorrhage'], ['Ergometrine', 'Postpartum hemorrhage'], ['Magnesium Sulphate', 'Eclampsia / Pre-eclampsia'], ['Nifedipine / Labetalol', 'Hypertensive emergency in pregnancy'], ], col_widths=[2.8, 3.6] ) add_sub_heading(doc, '2.4 Storage and Management of Emergency Drug Trolleys (Crash Carts)') for b in [ 'Emergency drug trolleys / crash carts placed in all critical areas: ICU, CCU, NICU, OT, Emergency Department, and each ward', 'Standardized layout with labeled compartments in every crash cart', 'Drugs stored in sealed trays or lock boxes - a broken seal immediately indicates unauthorized use', 'Temperature-sensitive drugs (epinephrine, insulin) stored at appropriate temperatures', 'Crash cart checked daily by duty nurse/pharmacist and after every use', 'Logbook maintained for each cart recording inspection date, seal number, and responsible staff', 'Expiry dates checked and documented; drugs nearing expiry replaced promptly', 'After an emergency event, the pharmacy restocks the crash cart within 1-2 hours', ]: add_bullet(doc, b) add_sub_heading(doc, '2.5 Review, Updating, and Staff Training') for b in [ 'EDL reviewed annually by the P&T Committee', 'Changes in clinical guidelines (updated ACLS/BLS protocols) trigger immediate review', 'New evidence on drug efficacy/safety in emergencies prompts reassessment', 'All clinical staff trained in location and correct use of emergency drugs', 'Regular mock codes (simulated emergency drills) conducted and documented', 'BLS and ACLS certification mandatory for ICU, ED, and OT staff', ]: add_bullet(doc, b) # ════════════════════════════════════════════════════════════════════════════ # PART III # ════════════════════════════════════════════════════════════════════════════ add_main_heading(doc, 'PART III: AUTOMATIC STOP ORDER POLICY') add_sub_heading(doc, '3.1 Definition') add_body(doc, 'An Automatic Stop Order (ASO) is a hospital policy that requires certain drug orders to be automatically discontinued - without explicit prescriber action - after a predetermined time period, unless the prescriber actively renews the order. It is a built-in safeguard against unintentional prolonged drug therapy.') add_body(doc, 'Reference - Katzung\'s Basic and Clinical Pharmacology (16th ed.): "If the duration of therapy or the number of doses is not specified (which is often the case), the medication is continued until the prescriber discontinues the order or until it is terminated as a matter of policy routine, e.g., a stop-order policy."', italic=True) add_sub_heading(doc, '3.2 Rationale and Need for Automatic Stop Orders') add_body(doc, 'The WHO Drug and Therapeutics Committee Practical Guide states: "Automatic stop orders are useful for hospital patients and will enforce restrictions on the period of time for which drugs are used... patients may be left on antibiotics for a long period of time because physicians have neglected to discontinue the medicine."') add_body(doc, 'Without automatic stop orders, patients may experience:') for b in [ 'Antibiotics continued for weeks due to physician oversight - promoting antimicrobial resistance', 'Controlled substances (opioids, benzodiazepines) continued beyond clinically necessary period', 'Post-operative drugs continued unnecessarily, increasing costs and adverse effects', 'Anticoagulants continued beyond the safe period, risking serious bleeding', 'Sedatives causing prolonged sedation in ICU or ward patients', ]: add_bullet(doc, b) add_sub_heading(doc, '3.3 Drug Categories Subject to Automatic Stop Orders') make_table(doc, ['Drug Category', 'Typical ASO Time Limit', 'Rationale'], [ ['Antibiotics (general)', '48-72 hours', 'Review culture reports; de-escalate therapy'], ['Surgical prophylactic antibiotics', '24-48 hours post-op', 'Extended use increases resistance risk'], ['Narcotic / Opioid analgesics', '48-72 hours', 'Prevent dependence; reassess pain level'], ['Anticoagulants (heparin, warfarin)', '72 hours or per protocol', 'Reassess bleeding risk; adjust doses'], ['Sedatives / Hypnotics', '48-72 hours', 'Prevent tolerance and dependence'], ['Controlled substances (Schedule I-II)', '48-72 hours', 'Legal compliance and clinical safety'], ['Corticosteroids (systemic)', '7 days', 'Reassess need; plan taper if continuing'], ['Antifungals', '72 hours', 'Review necessity and culture results'], ['IV fluids (specific orders)', '24 hours', 'Reassess fluid balance daily'], ['Total Parenteral Nutrition (TPN)', '24-48 hours', 'Daily reassessment of nutritional needs'], ], col_widths=[2.1, 1.5, 2.8] ) add_body(doc, 'Note: Exact time limits are determined by each hospital\'s P&T Committee based on clinical evidence and local practice.', italic=True) add_sub_heading(doc, '3.4 Drugs Exempt from Automatic Stop Orders') add_body(doc, 'The following are generally exempt (but still subject to periodic clinical review):') for b in [ 'Chronic maintenance drugs (antihypertensives, antidiabetics, cardiac drugs) continued from home', 'Thyroid replacement therapy', 'Drugs for chronic psychiatric conditions (antipsychotics, antidepressants) unless newly initiated', 'Insulin - routine maintenance doses for established diabetic patients', 'Drugs for chronic pain conditions under specialist supervision', ]: add_bullet(doc, b) add_sub_heading(doc, '3.5 Standard Procedure for Automatic Stop Orders') make_table(doc, ['Step', 'Action', 'Responsible Party'], [ ['Step 1: Order Entry', 'Drug category identified; ASO expiration timestamp assigned. EHR systems automate this; paper systems use pharmacist stamp', 'Pharmacist / EHR System'], ['Step 2: Advance Notification', 'Physician notified 24-48 hours before stop order takes effect via EHR alert, pharmacist call, or nursing notification', 'Pharmacist / Nursing'], ['Step 3: Physician Decision', 'Physician reviews clinical status and chooses: Renew / Modify / Allow to discontinue as scheduled', 'Treating Physician'], ['Step 4: Discontinuation', 'If no renewal received, order automatically discontinued. Pharmacy ceases dispensing; nursing does not administer further doses', 'Pharmacy + Nursing'], ['Step 5: Documentation', 'All ASO events logged in pharmacy system and patient chart (drug, date, time, reason for stop)', 'Pharmacist'], ['Step 6: Audit', 'P&T Committee reviews ASO compliance monthly/quarterly; corrective action for bypassed orders', 'P&T Committee'], ], col_widths=[1.5, 3.6, 1.3] ) add_sub_heading(doc, '3.6 Special Provisions') for b in [ 'Emergency override: Any authorized physician may override an ASO in critical situations with proper documentation', 'Surgical patients: Post-operative prophylactic antibiotic ASO is most rigidly enforced', 'ICU patients: ASO applied with clinical judgment; intensivist reviews all expiring orders daily', 'On inter-unit transfer: All drug orders reviewed; ASO timers may reset on admission to new unit', 'At discharge: All inpatient orders automatically cease; new prescription required for outpatient continuation', ]: add_bullet(doc, b) add_sub_heading(doc, '3.7 Benefits of Automatic Stop Order Policy') make_table(doc, ['Benefit', 'Details'], [ ['Reduces medication errors', 'Prevents unintentional prolonged therapy from oversight'], ['Prevents antimicrobial resistance', 'Limits unnecessary antibiotic use; supports stewardship'], ['Reduces adverse drug reactions', 'Shorter exposure reduces risk of dose-cumulative toxicity'], ['Decreases drug costs', 'Eliminates redundant or unnecessary drug utilization'], ['Ensures periodic reassessment', 'Clinician reviews drug need at every renewal point'], ['Improves prescriber accountability', 'Active renewal requires conscious clinical decision'], ['Supports antimicrobial stewardship', 'Core tool of Antimicrobial Stewardship Programs (ASP)'], ['Medico-legal protection', 'Documented stop orders reduce institutional liability'], ], col_widths=[2.2, 4.2] ) add_sub_heading(doc, '3.8 Challenges and Solutions') make_table(doc, ['Challenge', 'Solution'], [ ['Prescriber resistance / workflow disruption', 'Education; involve physicians in policy design from the start'], ['Risk of stopping a clinically necessary drug', '24-48 hr advance notification; easy, one-step renewal process'], ['Complex paper-based systems', 'EHR integration; dedicated pharmacist oversight of expiring orders'], ['Inconsistent application across departments', 'Standardized institution-wide policy; regular compliance audits'], ['Emergency situations requiring override', 'Clear override protocol with mandatory documentation'], ], col_widths=[2.8, 3.6] ) # ════════════════════════════════════════════════════════════════════════════ # PART IV - INTERRELATIONSHIP # ════════════════════════════════════════════════════════════════════════════ add_main_heading(doc, 'PART IV: INTERRELATIONSHIP OF THE THREE POLICIES') add_body(doc, 'These three policies are deeply interconnected within the hospital drug management system and together form the triad of rational drug use:') make_table(doc, ['Policy', 'Core Function', 'Governing Body'], [ ['Formulary Inclusion Policy', 'Determines WHICH drugs are available in the hospital', 'P&T Committee'], ['Emergency Drug List', 'Ensures CRITICAL drugs are always immediately accessible', 'P&T Committee + Pharmacy'], ['Automatic Stop Orders', 'Regulates HOW LONG drugs are used once prescribed', 'P&T Committee + Prescribers'], ], col_widths=[2.0, 3.0, 1.4] ) add_body(doc, 'Together they are aligned with:') for b in [ 'WHO Essential Medicines Concept', 'ASHP Formulary System Guidelines', 'Joint Commission International (JCI) Accreditation Standards', 'NABH (National Accreditation Board for Hospitals) Standards - India', 'National Pharmaceutical Pricing Authority (NPPA) Drug Policy - India', ]: add_bullet(doc, b) # ════════════════════════════════════════════════════════════════════════════ # CONCLUSION # ════════════════════════════════════════════════════════════════════════════ add_main_heading(doc, 'CONCLUSION') add_body(doc, 'Hospital drug policies are the foundation of safe and rational drug use. The formulary inclusion policy ensures only evidence-based, cost-effective, and safe drugs are stocked and used, guided by a transparent and structured evaluation process led by the P&T Committee. The emergency drug list guarantees that life-saving drugs are available within seconds when a patient\'s life is at risk, with standardized crash carts, regular inspection, and staff training. The automatic stop order policy acts as a systematic safeguard against unintentional prolonged prescribing, reducing adverse effects, resistance, costs, and prescribing errors.') add_body(doc, 'Effective implementation of all three policies requires strong institutional commitment, interdisciplinary collaboration, regular audit, and continuous staff education. Pharmacists play a central and indispensable role in developing, implementing, monitoring, and improving each of these policies - contributing directly to patient safety and quality of care.') # ════════════════════════════════════════════════════════════════════════════ # REFERENCES # ════════════════════════════════════════════════════════════════════════════ add_main_heading(doc, 'REFERENCES') refs = [ 'Katzung BG, Vanderah TW. Basic and Clinical Pharmacology, 16th ed. McGraw-Hill; 2021. Chapter 66: Prescribing Principles.', 'World Health Organization. Drug and Therapeutics Committees: A Practical Guide. WHO/EDM/PAR/2004.1. Geneva: WHO; 2004.', 'American Society of Health-System Pharmacists (ASHP). Draft ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System; 2019.', 'Ministry of Health, Saudi Arabia. National Formulary Drug List: Drug Control Policies and Guidelines; 2020.', 'University of Toledo Medical Center. Pharmacy and Therapeutics Committee Policy 3364-87-19; 2023.', 'Joint Commission International. Accreditation Standards for Hospitals, 7th ed; 2021.', 'National Accreditation Board for Hospitals and Healthcare Providers (NABH). Standards for Hospitals, 5th ed. New Delhi: Quality Council of India; 2020.', 'Tietz Textbook of Laboratory Medicine, 7th ed. Elsevier; 2023. Section: The Laboratory Stewardship/Test Utilization Committee.', ] for i, ref in enumerate(refs, 1): p = doc.add_paragraph() p.paragraph_format.space_before = Pt(2) p.paragraph_format.space_after = Pt(3) p.paragraph_format.left_indent = Inches(0.3) p.paragraph_format.first_line_indent = Inches(-0.3) run = p.add_run(f'{i}. {ref}') run.font.size = Pt(10) run.font.name = 'Calibri' run.font.color.rgb = TEXT_BLACK # ── Footer with page numbers ───────────────────────────────────────────────── from docx.oxml.ns import nsmap as docx_nsmap def add_footer_with_page_number(doc): section = doc.sections[0] footer = section.footer para = footer.paragraphs[0] if footer.paragraphs else footer.add_paragraph() para.alignment = WD_ALIGN_PARAGRAPH.CENTER para.clear() run = para.add_run('Hospital Drug Policies Assignment | Page ') run.font.size = Pt(9) run.font.name = 'Calibri' run.font.color.rgb = RGBColor(0x88, 0x88, 0x88) # page number field fldChar1 = OxmlElement('w:fldChar') fldChar1.set(qn('w:fldCharType'), 'begin') instrText = OxmlElement('w:instrText') instrText.text = 'PAGE' fldChar2 = OxmlElement('w:fldChar') fldChar2.set(qn('w:fldCharType'), 'separate') fldChar3 = OxmlElement('w:fldChar') fldChar3.set(qn('w:fldCharType'), 'end') run2 = para.add_run() run2.font.size = Pt(9); run2.font.name = 'Calibri' run2.font.color.rgb = RGBColor(0x88,0x88,0x88) for el in [fldChar1, instrText, fldChar2, fldChar3]: run2._r.append(el) add_footer_with_page_number(doc) # ── Save ───────────────────────────────────────────────────────────────────── out_path = '/tmp/workspace/hospital-drug-policy/Hospital_Drug_Policies_Assignment.docx' doc.save(out_path) print(f'SAVED: {out_path}') PYEOF echo "Script written successfully"

Running Command

cd /tmp/workspace/hospital-drug-policy && python3 create_doc.py

Running Command

python3 -c " from docx import Document doc = Document('/tmp/workspace/hospital-drug-policy/Hospital_Drug_Policies_Assignment.docx') count = sum(1 for p in doc.paragraphs if p.text.strip()) tables = len(doc.tables) print(f'Non-empty paragraphs: {count}') print(f'Tables: {tables}') import os size = os.path.getsize('/tmp/workspace/hospital-drug-policy/Hospital_Drug_Policies_Assignment.docx') print(f'File size: {size:,} bytes ({size/1024:.1f} KB)') # Print first few headings for p in doc.paragraphs: if p.runs and any(r.bold for r in p.runs) and p.text.strip(): print(' HEADING:', p.text[:80]) if len([x for x in doc.paragraphs if x.text.strip()]) > 5: break "

Your Word file is ready. Download it here:

Hospital Drug Policies Assignment

Word Document · DOCX

What's inside the document (professional formatting):

Feature	Details
Cover banner	Dark blue title block with subtitle strip
Page setup	A4, 2.54 cm margins all sides
Font	Calibri 11pt body, Calibri 14pt/12pt headings
Headings	Dark blue (Part headings) + Mid-blue (sub-headings) with accent underline rules
14 styled tables	Blue header rows, alternating row shading, bordered cells
Bullet lists	Consistent indented bullet points throughout
Footer	Every page: "Hospital Drug Policies Assignment
References	Numbered, hanging-indent format
Sections	Introduction, Part I (Formulary Inclusion), Part II (Emergency Drug List), Part III (Automatic Stop Orders), Part IV (Interrelationship), Conclusion, References
Content	146 paragraphs, ~3,800 words, ~8 A4 pages

This is a shared conversation. Sign in to Orris to start your own chat.